Hidden in the forests of Canada is a small fungus with a very long history. Today, magic mushrooms are stepping into the spotlight in ways that are surprising even the scientific community.

What was once known only for its mind-altering effects is now drawing attention from researchers exploring new frontiers of human health. Some of the most exciting discoveries are pointing toward benefits that could reshape our understanding of wellness and vitality as we age.

Psilocybin and Healthy Ageing: What a New 2025 Study Reveals

The world of longevity research is buzzing in 2026, and one of the most surprising contenders making headlines is psilocybin, the naturally occurring psychedelic compound found in magic mushrooms. For decades, psilocybin has been studied almost exclusively for its potential to treat depression, anxiety, and PTSD, but a groundbreaking peer-reviewed paper published in July 2025 has shifted the conversation. Titled “Psilocybin treatment extends cellular lifespan and improves survival of aged mice,” the study (published in npj Aging, a Nature Portfolio journal) provides the first direct experimental evidence that psilocybin and its active metabolite psilocin may act as powerful geroprotective agents, compounds that help slow biological ageing at the cellular and organismal level.

Conducted by researchers at Baylor College of Medicine and Emory University, the study combined lab-based human cell experiments with a real-world longevity trial in aged mice. The results are striking: treated cells lived dramatically longer, and older mice showed improved survival rates and visible signs of healthier ageing. While this is still early-stage preclinical research, it opens an exciting new chapter in how we think about mushroom-derived compounds and whole-body wellness.

Key Findings in Human Cells

To test the effects on human biology, the team used two well-established cell models: IMR-90 fetal lung fibroblasts and adult human skin fibroblasts. These cell types are standard in ageing research because they mimic how our tissues lose function over time through a process called replicative senescence.

When the cells were treated with psilocin (the form psilocybin converts to in the body) at doses comparable to those used in human clinical trials, the results were impressive. Cellular lifespan increased by up to 57% compared with untreated controls. At moderate doses, the extension was around 29%, while higher therapeutic-range concentrations delivered the full 51–57% boost.

Beyond simply living longer, the treated cells behaved in ways associated with youthfulness. They delayed the onset of senescence, the point at which cells stop dividing and start secreting inflammatory signals that accelerate ageing throughout the body. Telomere length (the protective caps on chromosomes that shorten with every cell division) was better preserved. Oxidative stress markers dropped significantly, DNA repair pathways improved, and levels of the longevity protein SIRT1 rose.

In simple terms, psilocin didn’t just keep the cells alive; it helped them stay functionally younger for much longer. Full open-access study here: Psilocybin treatment extends cellular lifespan and improves survival of aged mice.

Results in Aged Mice

The animal arm of the study is what really caught the attention of the longevity community. Researchers worked with 19-month-old female mice, the mouse equivalent of roughly 60–65 years in humans. These animals received oral psilocybin once per month for 10 months: an initial low “priming” dose of 5 mg/kg followed by 15 mg/kg maintenance doses.

The outcomes were remarkable. In the control group, only 50% of the mice survived the full study period. In the psilocybin-treated group, survival jumped to 80%, a statistically significant 30-percentage-point improvement. Beyond survival numbers, the treated mice looked visibly healthier: their fur was thicker and glossier, hair regrowth was faster after shaving tests, and there was noticeably less graying.

Importantly, treatment started late in life, proving that psilocybin’s benefits aren’t limited to prevention; it may also offer meaningful “rescue” effects even when biological ageing is already advanced.

Baylor College of Medicine press release: Can psychedelic mushrooms turn back the clock?

How Psilocybin Appears to Support Healthy Ageing

The researchers connected these benefits to several core “hallmarks of ageing” first outlined by scientists in 2013 and updated in 2023. Psilocybin/psilocin reduced oxidative damage by lowering Nox4 activity while boosting Nrf2, a master regulator that turns on the body’s antioxidant defenses. Telomeres stayed longer, senescence markers such as p16, p21, and β-galactosidase dropped, and DNA stability improved.

One especially interesting angle involves serotonin receptors. While most people associate serotonin with mood, these receptors exist throughout the body, in the gut, immune system, blood vessels, and even on fibroblasts. The study suggests psilocybin’s systemic effects may work partly through these widespread receptors, creating a whole-body response rather than just brain-specific changes.

Biohackers like Bryan Johnson (Founder of Blueprint Longevity Project) are testing psilocybin for longevity. He tracked 249 biomarkers before and after, finding that his systemic inflammation dropped 35%. Brain scans also showed more youthful, flexible patterns and increased cognitive openness. 

Emory University coverage: Psilocybin may slow aging in human cells and mice

Medical News Today summary: Slowing aging: psilocybin helps extend lifespan in human cells and skin

PubMed: PMID 40628762

Important Limitations and Next Steps

As exciting as these findings are, it’s essential to stay grounded. This is preclinical research, human cells in dishes and mice in a lab. We still don’t know whether the same longevity effects will appear in people, what the ideal human dosing schedule would be, or how benefits might differ by age, sex, or existing health conditions. Some experts have noted that the mouse doses, when scaled to humans, are on the higher side of what’s typically used in therapy sessions, so safety and tolerability data in older adults will be critical.

That said, the doses align with those already being safely tested in ongoing mental-health trials. As of early 2026, several psilocybin studies for depression, chronic pain, and other conditions are underway, and researchers are beginning to discuss adding biological ageing markers to future protocols. 

Why This Matters for Mushroom Enthusiasts in Canada

For those already interested in functional mushrooms and microdosing, this 2025 study adds scientific weight to what many have felt intuitively: psilocybin-containing mushrooms may support more than just mental clarity. They could play a role in promoting healthier ageing from the inside out.

At Shroom Dudes, we’ve always focused on having premium magic mushroom products accessible and consistent. Our collection includes microdose capsules, teas, chocolates, dried mushrooms, and more, all produced right here in Canada.

If you’re exploring psilocybin for potential anti-ageing support, Shroom Dudes has exactly what you need.

Our low-dose microdosing capsules and delicious psilocybin chocolates are perfect for consistent daily or weekly routines that align with the kind of long-term use being studied for wellness and longevity. We also carry convenient teas and dried mushrooms so you can find the format that fits your lifestyle best. Every product is discreetly shipped across Canada and backed by our satisfaction guarantee.

Shop Microdosing, Chocolates & More at Shroom Dudes →